NEWS ARCHIVE

Tag: crowdfunding

Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…

We’re extremely excited to announce the launch of our second Regulation A+ equity crowdfunding campaign. Due to popular demand, we have re-opened the opportunity to invest in BIOLIFE4D’s life-saving technology! Since our first equity crowdfunding campaign, we’ve made exceptional progress – including the successful demonstration of 3D bioprinting human tissue, along with heart components like chambers,…

After a yearlong tremendously successful equity crowdfunding campaign, the ability to acquire equity in BIOLIFE4D and participate in the groundbreaking technology is quickly coming to an end.  There are now only 24 hours left to invest in BIOLIFE4D before the opportunity to do so closes – this Thursday January 31, 2019! Earlier this weekwe announced the appointment…

We’re down to the wire. In just one week we’ll be closing the opportunity to invest in BIOLIFE4D through our equity crowdfunding campaign. This is your last chance to be able to participate with us in bringing this incredible technology to the market.  It is your last chance to get in on the ground floor…

Heart disease kills more human beings than anything else on earth each year, accounting for 18 million deaths – about 31% of all global deaths. Solving heart disease has been one of humanity’s greatest challenges since the beginning of medicine but sadly, scientists have not been able to figure it out. The impact of deaths from…

The beginning of each year is a great time to get a lot of things in order, and one of those is finances and investments. Many people invest in vehicles like index funds that spread their money across a large number of companies, and often don’t keep track of where their money goes. At the…

January 2019 is the final month to invest in BIOLIFE4D’s Regulation A+ offering to participate in the groundbreaking technology of 3D bioprinting human hearts viable for transplant. If you’re not familiar, in February 2018, BIOLIFE4D launched this offering to allow both accredited and non-accredited potential investors to consider helping us bring this historical, lifesaving technology…

It’s that time of the year again: the end – and many people will use this time to look back at how they lived this year, and how they can better themselves in the next. In addition to finding new ways to help themselves, many people will think about new ways that they can help…

In our efforts to save human lives by fighting heart disease and heart shortages, 2018 was our busiest year to date. With the help of a world-class team and forward-thinking investors, we have already made major scientific and biological strides and hope to begin bringing our incredible technology to the market by the end of…

The end-of-year holiday season brings families and friends together, and many people will be asked by loved ones what they would like to receive as gifts. These gifts can thoughtfully demonstrate an understanding of what the recipients enjoy or what matters most to them. To find these gifts, many people will head to shopping malls or…

Build a Heart. Save a life.

Scroll Up